Nationwide Fund Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-119,722
| Closed | -$42K | – | 3276 |
|
|
2016
Q3 | $42K | Hold |
119,722
| – | – | ﹤0.01% | 3074 |
|
|
2016
Q2 | $56K | Hold |
119,722
| – | – | ﹤0.01% | 3061 |
|
|
2016
Q1 | $163K | Buy |
119,722
+15,547
| +15% | +$21.2K | ﹤0.01% | 2624 |
|
|
2015
Q4 | $153K | Hold |
104,175
| – | – | ﹤0.01% | 2672 |
|
|
2015
Q3 | $165K | Hold |
104,175
| – | – | ﹤0.01% | 2668 |
|
|
2015
Q2 | $177K | Buy |
104,175
+12,310
| +13% | +$20.9K | ﹤0.01% | 2770 |
|
|
2015
Q1 | $128K | Buy |
91,865
+1,334
| +1% | +$1.86K | ﹤0.01% | 2891 |
|
|
2014
Q4 | $137K | Sell |
90,531
-1,651
| -2% | -$2.5K | ﹤0.01% | 2817 |
|
|
2014
Q3 | $190K | Buy |
92,182
+710
| +0.8% | +$1.46K | ﹤0.01% | 2717 |
|
|
2014
Q2 | $280K | Buy |
91,472
+7,436
| +9% | +$22.8K | ﹤0.01% | 2580 |
|
|
2014
Q1 | $210K | Buy |
84,036
+5,049
| +6% | +$12.6K | ﹤0.01% | 2472 |
|
|
2013
Q4 | $392K | Buy |
78,987
+7,514
| +11% | +$37.3K | ﹤0.01% | 2354 |
|
|
2013
Q3 | $162K | Buy |
71,473
+44,779
| +168% | +$101K | ﹤0.01% | 2767 |
|
|
2013
Q2 | $59K | Buy |
+26,694
| New | +$59K | ﹤0.01% | 2930 |
|
Nationwide Fund Advisors's RXII Position: Q4 2016 in Review
Nationwide Fund Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 119,722 shares — an estimated $42K sold.
Nationwide Fund Advisors first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $392K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Nationwide Fund Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Nationwide Fund Advisors sold 119,722 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $42K.
- Nationwide Fund Advisors first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- Nationwide Fund Advisors's GALENA BIOPHARMA INC COM position peaked at $392K in Q4 2013.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Nationwide Fund Advisors's 13F filing for Q4 2016, filed 27 Jan 2017.